Trial intelligence / Profile preview

Anesthetic Contribution in Corticosteroid Injections for Knee OA

NCT02576249Phase 4Completed

Sponsor
Mayo Clinic
Start
Oct 2015
Primary completion
Jul 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine in osteoarthritis (OA), sponsored by Mayo Clinic. Started Oct 2015; status: completed.

02

Drugs

ropivacaine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02576249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02576249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call